Threshold Pharma (Nasdaq: THLD) announced that the Independent Data Monitoring Committee (IDMC) has completed the planned interim efficacy and safety ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE